Home  | About mdi |  Services  | Industries | News & Information | Partners | Contact| Site Map

May 23 – May 29

May 23rd: Cardinal Health Completes Acquisition of Denver Biomedical, a Manufacturer of Specialized Medical Devices

Cardinal Health, Inc, the leading provider of products and services supporting the health-care industry, today announced it has completed the acquisition of Denver Biomedical, Inc., a designer and manufacturer of specialized medical products for chronic fluid management in the chest and abdomen. Terms of the agreement were not disclosed.

Based in Golden, Colorado, Denver Biomedical has 50 employees. It markets specialty drainage products worldwide for hospital and home use, primarily for terminally-ill cancer patients. Founded in 1969, Denver Biomedical's products include the Pleurx® Pleural Catheter System, the Denver® Ascites Shunt, and the Denver® Pleural Effusion Shunt. Denver Biomedical was the first company to receive FDA clearance specifically for an indwelling catheter for drainage of chronic pleural and ascitic fluids.

The chronic fluid drainage market provides a vital service to patients, providing at-home relief for fluid build-up. This acquisition supports Cardinal Health's strategic focus and rounds out the company's growing Para/Thoracentesis product offering.

May 24th: Endologix Receives FDA Approval for Visiflex Delivery System

Endologix, Inc today announced receipt of U.S. Food and Drug Administration (FDA) approval to begin marketing its next-generation Visiflex(TM) Delivery System for use with the Powerlink® System for the minimally invasive treatment of abdominal aortic aneurysm (AAA).

The Visiflex Delivery System is designed to provide improved catheter flexibility for delivery of the Powerlink endoluminal stent graft (ELG) device. An integrated radiopaque band marker on the outer sheath and molded component parts are expected to enhance catheter visibility and facilitate smoother withdrawal in difficult anatomies. The Visiflex Delivery System has been CE Marked and used in Europe in Powerlink procedures, with very positive physician feedback to date.

Endologix, Inc. develops and manufactures minimally invasive treatments for vascular diseases. Endologix's Powerlink System is an endoluminal stent graft (ELG) for treating abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement.

Home  | About mdi |  Services  | Industries | News & Information | Partners | Contact| Site Map